Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Preferred Stock
Series A Preferred Stock
Preferred Stock
Series B Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balance at beginning of period at Dec. 31, 2024 $ 49   $ 90 $ 1,298,747 $ 73 $ (1,237,057) $ 61,902
Balance at beginning of period (in shares) at Dec. 31, 2024 984,000 2,000 11,952,000        
Increase (Decrease) in Stockholders' Equity              
Exercise of stock options       85     85
Exercise of stock options (in shares)     21,000        
Stock-based compensation expense - equity-classified       1,983     1,983
Issuance of common stock related to 401(k) contribution       141     141
Issuance of common stock related to 401(k) contribution (in shares)     5,000        
Repurchase of common stock           (545) (545)
Repurchase of common stock (in shares)     (25,000)        
Preferred stock dividends       (1,368)     (1,368)
Net unrealized gain (loss) on available-for-sale debt securities         45   45
Net Income (Loss)           2,367 2,367
Balance at end of period at Mar. 31, 2025 $ 49   $ 90 1,299,588 118 (1,235,235) 64,610
Balance at end of period (in shares) at Mar. 31, 2025 984,000 2,000 11,953,000        
Balance at beginning of period at Dec. 31, 2025 $ 49   $ 89 1,305,200 53 (1,221,450) 83,941
Balance at beginning of period (in shares) at Dec. 31, 2025 984,000 2,000 11,859,000        
Increase (Decrease) in Stockholders' Equity              
Exercise of stock options       518     $ 518
Exercise of stock options (in shares)     33,000       33,278
Stock-based compensation expense - equity-classified       1,969     $ 1,969
Issuance of common stock related to 401(k) contribution       124     124
Issuance of common stock related to 401(k) contribution (in shares)     5,000        
Issuance of common stock related to PSUs (in shares)     24,000        
Repurchase of common stock           (264) $ (264)
Repurchase of common stock (in shares)     (11,000)       (10,902)
Reclassification of liability classified awards to equity classified awards       3,509     $ 3,509
Preferred stock dividends       (1,452)     (1,452)
Net unrealized gain (loss) on available-for-sale debt securities         66   66
Net Income (Loss)           4,465 4,465
Balance at end of period at Mar. 31, 2026 $ 49   $ 89 $ 1,309,868 $ 119 $ (1,217,249) $ 92,876
Balance at end of period (in shares) at Mar. 31, 2026 984,000 2,000 11,910,000